Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | GSK3B | P49841 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.31 |
| ▸ | CES2 | O00748 | 2/20 | 0.31 |
| ▸ | CES1 | P23141 | 2/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5453551 | 0.97 | TDP1 (0.63) | TDP1CYP3A4ESR1ESR2KDM4E | |
| SCHEMBL319391 | 0.92 | TDP1 (0.63) | TDP1CYP3A4ESR1ESR2KDM4E | |
| SCHEMBL2648008 | 0.89 | CYP3A4 (0.48) | TDP1CYP3A4ESR1ESR2PTGS2 | |
| SCHEMBL9169189 | 0.89 | CYP3A4 (0.48) | TDP1CYP3A4ESR1ESR2PTGS2 | |
| SCHEMBL10370405 | 0.89 | CYP3A4 (0.48) | TDP1CYP3A4ESR1ESR2PTGS2 | |
| SCHEMBL17501902 | 0.89 | CYP3A4 (0.48) | TDP1CYP3A4ESR1ESR2MAPT | |
| SCHEMBL18729718 | 0.89 | CYP3A4 (0.48) | TDP1CYP3A4ESR1ESR2MAPT | |
| SCHEMBL5565882 | 0.89 | CYP3A4 (0.48) | TDP1CYP3A4ESR1ESR2PTGS2 | |
| SCHEMBL10810735 | 0.89 | CYP3A4 (0.48) | TDP1CYP3A4ESR1ESR2PTGS2 | |
| SCHEMBL8165832 | 0.89 | CYP3A4 (0.48) | TDP1CYP3A4ESR1ESR2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114008057-A | 3, 5-bis (phenyl) -1H-heteroaryl derivatives as medicaments | 捷克共和国科学院生物技术研究所 | 2022-02-01 | — | — | CN | disclosed |
| EP-3655414-A1 | DEFEROXAMINE DERIVATIVES AS MEDICAMENTS | Biotechnologicky Ustav AV CR, V.V.I. (CZ) | 2020-05-27 | — | — | EP | disclosed |
| US-20200078379-A1 | DEFEROXAMINE DERIVATIVES AS MEDICAMENTS | BIOTECHNOLOGICKY USTAV AV CR, V.V.I (CZ) | 2020-03-12 | — | — | US | disclosed |
| WO-2019015701-A1 | DEFEROXAMINE DERIVATIVES AS MEDICAMENTS | BIOTECHNOLOGICKY USTAV AV CR, V.V.I. (CZ) | 2019-01-24 | — | — | WO | disclosed |
| WO-2016155679-A1 | TRIPHENYLPHOSPHONIUM BIGUANIDE ANALOGUES, THEIR METHOD OF PREPARATION AND USE AS DRUGS | KKCG SE (CY) | 2016-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200078379-A1 | DEFEROXAMINE DERIVATIVES AS MEDICAMENTS | SLC40A1, TFRC, FOLR2 | TDP1 2341/4885CYP3A4 824/4885ESR1 1639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.